
ResMed RMD
$ 245.71
0.37%
Annual report 2022
added 08-12-2022
ResMed DPO Ratio 2011-2026 | RMD
Annual DPO Ratio ResMed
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.9 | 36.8 | 37 | 39.5 | 34.6 | 39.1 | 43.8 | 44.4 | 55.2 | 38.6 | 36.7 | 40.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.2 | 34.6 | 40.1 |
Quarterly DPO Ratio ResMed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 38.3 | 39.4 | 35.8 | 16 | 36.9 | 32.4 | 36.9 | 36.7 | 36.4 | 33.1 | 35.5 | 34.2 | 37.4 | 34.5 | 35.6 | 31.6 | 31.8 | 29.6 | 37.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 39.4 | 16 | 34.2 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
Baxter International
BAX
|
50.7 | $ 20.11 | 3.08 % | $ 10.3 B | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 199.29 | 2.23 % | $ 57.3 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
73.7 | $ 8.32 | 6.19 % | $ 168 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
47.4 | $ 0.69 | 6.06 % | $ 29.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
63.6 | $ 80.82 | 4.15 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
12.6 | $ 185.48 | 5.86 % | $ 5.79 B | ||
|
AtriCure
ATRC
|
81.2 | $ 40.81 | 3.91 % | $ 1.92 B | ||
|
Repro Med Systems
KRMD
|
52 | $ 5.59 | -0.36 % | $ 255 M | ||
|
electroCore
ECOR
|
279 | $ 4.75 | 4.29 % | $ 26.2 K | ||
|
LeMaitre Vascular
LMAT
|
14.5 | $ 82.24 | 2.58 % | $ 1.85 B | ||
|
ICU Medical
ICUI
|
34.9 | $ 144.42 | 4.25 % | $ 3.52 B | ||
|
AngioDynamics
ANGO
|
96.2 | $ 13.22 | 4.22 % | $ 540 M | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 83.19 | 2.56 % | $ 16.6 B | ||
|
Merit Medical Systems
MMSI
|
34.4 | $ 88.65 | 2.54 % | $ 5.16 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 113.43 | 2.38 % | $ 5.49 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 81.85 | 2.31 % | $ 4.12 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 8.79 | 4.77 % | $ 182 M | ||
|
Nephros
NEPH
|
50.5 | $ 4.93 | 3.79 % | $ 51.2 M | ||
|
Masimo Corporation
MASI
|
84.4 | $ 133.69 | 4.94 % | $ 7.13 B | ||
|
OraSure Technologies
OSUR
|
36.6 | $ 2.47 | 3.78 % | $ 184 M | ||
|
Intuitive Surgical
ISRG
|
25.7 | $ 564.19 | 0.39 % | $ 200 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.1 | -0.71 % | $ 21.4 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.3 | 2.44 % | $ 23.9 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
56.8 | $ 22.52 | 3.92 % | $ 3.88 B | ||
|
STERIS plc
STE
|
31.8 | $ 256.06 | 2.43 % | $ 25.2 B | ||
|
Stereotaxis
STXS
|
99 | $ 2.4 | 3.66 % | $ 194 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 38.78 | 2.81 % | $ 128 M | ||
|
Predictive Oncology
POAI
|
547 | - | - | $ 32.4 M | ||
|
Pulse Biosciences
PLSE
|
68.4 | $ 14.89 | 11.2 % | $ 715 M | ||
|
Utah Medical Products
UTMD
|
18 | $ 58.16 | 2.94 % | $ 211 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 169.9 | 3.38 % | $ 9.47 M | ||
|
BioLife Solutions
BLFS
|
130 | $ 25.31 | 5.94 % | $ 1.17 B | ||
|
Retractable Technologies
RVP
|
48.6 | $ 0.76 | 0.01 % | $ 22.8 M | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 24.0 | 1.69 % | $ 1.18 B | ||
|
Teleflex Incorporated
TFX
|
37.1 | $ 124.76 | 1.84 % | $ 5.84 B | ||
|
West Pharmaceutical Services
WST
|
46.4 | $ 278.29 | 0.68 % | $ 20.3 B | ||
|
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.7 | 3.77 % | $ 2.38 B |